title: Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels.
authors.affiliation: Yale University Cardiovascular Disease Prevention Center, New Haven, Connecticut.
authors.forename: J L
authors.initials: JL
authors.lastname: Isaacsohn
authors.forename: J F
authors.initials: JF
authors.lastname: Setaro
authors.forename: C
authors.initials: C
authors.lastname: Nicholas
authors.forename: J A
authors.initials: JA
authors.lastname: Davey
authors.forename: L J
authors.initials: LJ
authors.lastname: Diotalevi
authors.forename: D S
authors.initials: DS
authors.lastname: Christianson
authors.forename: E
authors.initials: E
authors.lastname: Liskov
authors.forename: E A
authors.initials: EA
authors.lastname: Stein
authors.forename: H R
authors.initials: HR
authors.lastname: Black
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008148:Lovastatin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*
chemical_list: D008055:Lipids; D017395:Plasminogen Activator Inhibitor 1; D008148:Lovastatin